These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 36225939)

  • 21. Integrated Analysis of Multi-Omics Data to Establish a Hypoxia-Related Prognostic Model in Osteosarcoma.
    Tong Y; Zhang X; Zhou Y
    Evol Bioinform Online; 2022; 18():11769343221128537. PubMed ID: 36325183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of risk model based on glycolysis-related genes in the metastasis of osteosarcoma.
    Huang W; Xiao Y; Wang H; Chen G; Li K
    Front Endocrinol (Lausanne); 2022; 13():1047433. PubMed ID: 36387908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing.
    Qin Z; Luo K; Liu Y; Liao S; He J; He M; Xie T; Jiang X; Li B; Liu H; Huang Q; Tang H; Feng W; Zhan X
    Int J Gen Med; 2022; 15():1033-1045. PubMed ID: 35140506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining bulk RNA-sequencing and single-cell RNA-sequencing data to reveal the immune microenvironment and metabolic pattern of osteosarcoma.
    Huang R; Wang X; Yin X; Zhou Y; Sun J; Yin Z; Zhu Z
    Front Genet; 2022; 13():976990. PubMed ID: 36338972
    [No Abstract]   [Full Text] [Related]  

  • 25. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
    Guo J; Li X; Shen S; Wu X
    Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MCAM is associated with metastasis and poor prognosis in osteosarcoma by modulating tumor cell migration.
    Du X; Zhang Q; Wang S; Chen X; Wang Y
    J Clin Lab Anal; 2022 Feb; 36(2):e24214. PubMed ID: 34961985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification and clinical significance of immunogenic cell death-related genes in Plasmodium falciparum infection determined by integrated bioinformatics analysis and machine learning.
    Zhang YH; Xie LH; Li J; Qi YW; Shi JJ
    Malar J; 2024 Feb; 23(1):48. PubMed ID: 38360586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma Based on an Integrative Analysis.
    Dai Z; Liu Z; Yang R; Cao W; Ji T
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-cell RNA datasets and bulk RNA datasets analysis demonstrated
    Tu J; Wang D; Zheng X; Liu B
    Front Immunol; 2023; 14():911368. PubMed ID: 36814925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Immunogenic Cell-Death-Related Subtypes and Development of a Prognostic Signature in Gastric Cancer.
    Gan X; Tang X; Li Z
    Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis-related genes-based prognostic signature for osteosarcoma.
    Yang F; Zhang Y
    Aging (Albany NY); 2022 May; 14(9):3813-3825. PubMed ID: 35504036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
    Xu HH; Wang HL; Xing TJ; Wang XQ
    Front Immunol; 2022; 13():851622. PubMed ID: 35924232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Prognostic Model Established by the Differential Expression Genes Based on CD8
    Chen Y; Yan W; Wang H; Ou Z; Chen H; Huang Z; Yang J; Liu B; Ou F; Zhang H
    Mediators Inflamm; 2023; 2023():6563609. PubMed ID: 36816742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients.
    Liu B; Liu XY; Wang GP; Chen YX
    Sci Rep; 2024 Mar; 14(1):5184. PubMed ID: 38431660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated analysis of single-cell RNA-seq dataset and bulk RNA-seq dataset constructs a prognostic model for predicting survival in human glioblastoma.
    Lai W; Li D; Kuang J; Deng L; Lu Q
    Brain Behav; 2022 May; 12(5):e2575. PubMed ID: 35429411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and Development of a Novel 4-Gene Immune-Related Signature to Predict Osteosarcoma Prognosis.
    Cao M; Zhang J; Xu H; Lin Z; Chang H; Wang Y; Huang X; Chen X; Wang H; Song Y
    Front Mol Biosci; 2020; 7():608368. PubMed ID: 33425993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of Molecular Subtype and Prognosis Prediction Model of Osteosarcoma Based on Aging-Related Genes.
    Dong C; Sun Y; Zhang Y; Qin B; Lei T
    J Oncol; 2022; 2022():8177948. PubMed ID: 36157228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
    Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
    Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
    Wang H; Li J; Li X
    Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma.
    Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y
    Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.